Pharmacogenomics: an evolving paradigm for drug therapy
Read, C.Y.
Medsurg Nursing Official Journal of the Academy of Medical-Surgical Nurses 11(3): 122-124
2002
ISSN/ISBN: 1092-0811 PMID: 12080569 Document Number: 543426
Individual variations in drug responsiveness are becoming better understood as a result of advances in genetics. The new science of pharmacogenomics capitalizes on that knowledge and promises safer and more powerful drug therapies.
Document emailed within 1 workday
Related Documents
Oyelese, Y. 2005: Prenatal care: examining the evidence for an evolving paradigm American Family Physician 71(7): 1264; 1266Müller, M. 2003: Pharmacogenomics and drug response International Journal of Clinical Pharmacology and Therapeutics 41(6): 231-240
Zhou, Q.; Yu, L.-s.; Zeng, S. 2017: Personalized dosing from perspective of pharmacogenomics of drug metabolizing enzymes and transporters Yao Xue Xue Bao 52(1): 1-7
Di Francia, R.; Siesto, R.S.; Valente, D.; Spart, D.; Berretta, M. 2012: Pharmacogenomics panel test for prevention toxicity in patient who receive Fluoropirimidine/Oxaliplatin-based therapy European Review for Medical and Pharmacological Sciences 16(9): 1211-1217
Hara, H. 2011: Paradigm shift in drug design Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 138(4): 133-134
Prathipati, P.; Mizuguchi, K. 2016: Systems Biology Approaches to a Rational Drug Discovery Paradigm Current Topics in Medicinal Chemistry 16(9): 1009-1025
Weetman, D.; Djogbenou, L.S.; Lucas, E. 2018: Copy number variation (CNV) and insecticide resistance in mosquitoes: evolving knowledge or an evolving problem? Current Opinion in Insect Science 27: 82-88
Best, D.W.; Lubman, D.I. 2012: The recovery paradigm - a model of hope and change for alcohol and drug addiction Australian Family Physician 41(8): 593-597
Wilkins, C. 2011: A paradigm shift in recreational drug use: the challenge of legal highs in New Zealand New Zealand Medical Journal 124(1339): 99-101
Miller, H.I. 1982: Recombinant DNA as a paradigm of a new technology: its impact on regulation by the Food and Drug Administration Journal of Parenteral Science and Technology: a Publication of the Parenteral Drug Association 36(6): 248-250
Stańczak, G.P.; Stańczak, J.J.; Marczyńska, M.; Firlag-Burkacka, E.; Wiercińska-Drapało, A.; Leszczyszyn-Pynka, M.; Jabłonowska, E.; Małolepsza, E.; Dyda, T.; Zabek, P.; Horban, A. 2010: Evolving patterns of HIV-1 transmitted drug resistance in Poland in the years 2000-2008 Journal of medical virology 82(7): 1291-1294
Phillips, S.J.; Zeff, R.H.; Kongtahworn, C.; Iannone, L.; Brown, T.M.; Zeff, R.L.; Beshany, S.; Gordon, D.F. 1981: Surgical therapy for evolving myocardial infarction: Results in 138 patients Herz 6(1): 55-61
Golanov, A.V.; Banov, S.M.; Vetlova, E.R. 2015: Metastatic brain lesion paradigm shift in radiation therapy Voprosy Onkologii 61(4): 530-545
Hearse, D.J.; Richard, V.; Yellon, D.M.; Kingma, J.G. 1988: Evolving myocardial infarction in the rat in vivo: an inappropriate model for the investigation of drug-induced infarct size limitation during sustained regional ischaemia Journal of Cardiovascular Pharmacology 11(6): 701-710
Isakova, V.A. 2006: New paradigm of the GERB and long-term therapy with proton pump inhibitors Eksperimental'naia i Klinicheskaia Gastroenterologiia 4: 53-58
Chakravarthy, K.; Manchikanti, L.; Kaye, A.D.; Christo, P.J. 2018: Reframing the Role of Neuromodulation Therapy in the Chronic Pain Treatment Paradigm Pain Physician 21(6): 507-513
Conroy, A.; Yeatman, S.; Dovel, K. 2013: The social construction of AIDS during a time of evolving access to antiretroviral therapy in rural Malawi Culture Health and Sexuality 15(8): 924-937
Oehme, P.; Brüschke, G.; Kluchert, K.; Krüger, U. 1970: Current problems of drug therapy. 9. Stationary and ambulatory drug therapy. 2 Das Deutsche Gesundheitswesen 25(21): 957-960
Weinberg, B.A.; Marshall, J.L.; Hartley, M.; Salem, M.E. 2016: A paradigm shift from one-size-fits-all to tailor-made therapy for metastatic colorectal cancer Clinical Advances in Hematology and Oncology: H&o 14(2): 116-128
Walsh, J.; Murphy, D.M. 2019: Combination Inhaled Corticosteroid/Long Acting Beta Agonist Therapy- An Evolving Role in Asthma Care Irish Medical Journal 112(2): 864